NAD Recommends that Young Living Essential Oils Discontinue “Therapeutic Grade” and Health-Related Claims for its Essential Oils; Advertiser to Appeal
For Immediate Release
Contact: Abby Hills, Director of Communications, BBB National Programs
301.412.7769 / firstname.lastname@example.org
New York, NY – July 22, 2020 – The National Advertising Division (NAD) recommended that Young Living Essential Oil, LC (Young Living) discontinue unsupported, health-related essential oil product claims of “therapeutic grade” and physical and/or mental health benefits, as these claims are unsupported. NAD also determined that certain challenged claims constitute permissible puffery which do not require substantiation. The claims at issue were challenged by S.C. Johnson & Son, Inc. Young Living said it will appeal NAD’s decision to the National Advertising Review Board.
NAD reviewed Young Living’s claim that its essential oils are “therapeutic” grade, and a range of specific claims that Young Living makes regarding the benefits of its oils. NAD determined that the claim of “therapeutic grade” conveys an unsupported message that the essential oils confer a beneficial healing physical or mental health effect on the body or mind. The advertiser argued that its “therapeutic grade” claim does not convey a medicinal or healing message, relying on the results of a consumer perception survey. After considering the survey methodology and results, NAD concluded that this survey was fundamentally flawed. NAD also considered the results of a consumer perception survey conducted by the challenger and determined that it was sufficiently reliable to demonstrate that Young Living’s “therapeutic grade” claim reasonably conveys a message that the essential oils provide a healthy or medicinal benefit, not simply a message of purity and quality. NAD came to a similar conclusion using its own expertise and judgment, noting that, at the very least, the reasonable consumer takeaway from this claim is that the oils provide some physical or mental benefit.
NAD noted that specific product testing, in the form of competent and reliable scientific evidence, is required as support for the advertiser’s specific health-related benefit claims. However, Young Living did not submit any studies conducted on its essential oils and did not make the requisite showing that the results of the studies relied upon can be reliably extrapolated to support the claims. This includes claims that the advertiser’s essential oils:
Will calm or relax consumers when applied or diffused, such as Dragon Time “can help promote feelings of stability and calm during occasional times of moodiness”;
Will help relieve consumers’ feelings of anxiety when applied (or diffused), such as Bergamot Oil “[m]ay help relieve tension during times of occasional stress”;
Will help consumers sleep, such as RC oil “May help support restful sleep” and other sleep related claims;
Will bring product users clarity, focus, or alertness when applied (or diffused) as directed, such as “Brain Power is a blend of essential oils . . . to promote a sense of clarity and focus when used aromatically”;
Can be used to treat symptoms associated with depression, such as Davana oil “boosts your positive outlook on life”; and
Will help consumers increase or maintain their energy levels when applied (or diffused) as directed, such as Peppermint “helps to maintain energy levels when applied topically.”
The advertiser agreed to permanently discontinue several claims that its essential oils and/or certain ingredients in the products:
Promote feelings of calm and relaxation
Help consumers sleep
Provide clarity, focus, and/or alertness
Improve consumers’ mood and increase their motivation
Therefore, NAD did not review these claims on their merits. NAD also determined that certain challenged claims constitute permissible puffery, which do not require substantiation.
In its advertiser’s statement, Young Living stated that it “disagrees with, and will appeal to NARB, NAD’s failure to credit valid survey data and published research in support of ‘therapeutic grade’ claims and claims that certain, carefully formulated products promote stability, calmness, relaxation, sleep, stress and tension relief, clarity, focus, energy, rational decision making, and alertness.”
About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. This independent, non-profit organization enhances trust, innovation, and competition in the marketplace through the development and delivery of cost-effective, third-party self-regulation, dispute resolution, and accountability programs. BBB National Programs’ 10 leading industry self-regulation and dispute resolution programs resolve business issues of national and international importance, and fosters industry best practices in truth-in-advertising, child-directed marketing, data privacy, and dispute resolution. To learn more about industry self-regulation, visit bbbprograms.org.
About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.
Children’s Advertising Review Unit Determines that Visual Supply Company App Is Not “Directed Primarily or Secondarily to Children”
DSSRC Refers Health-Related Product and Earnings Claims for Gano Excel to FTC
McLean, VA – January 13, 2021 – The Direct Selling Self-Regulatory Council (DSSRC) referred certain product performance and income claims made by Gano Excel USA to the Federal Trade Commission (FTC) for possible enforcement action after Gano Excel failed to provide substantiation for the claims.
NARB Refers Health-Related Claims for Theraworx Relief for Muscle and Joint Products to the FTC
New York, NY – January 12, 2021 – A panel of the National Advertising Review Board (NARB) has referred advertising claims made by Avadim Health, Inc. to the Federal Trade Commission (FTC) for review and possible enforcement action. The referral comes after the company declined to comply with a NARB recommendation to discontinue...
NAD Recommends Zarbee’s Inc. Qualify Use of the Term “Natural” in its Brand-Name for Some of its Dietary Supplement Products, and Modify Additional Claims
New York, NY – January 7, 2021 – The National Advertising Division (NAD) recommended that Zarbee’s qualify its use of the term “natural” in the Zarbee’s Naturals brand name when some or all the essential or key ingredients used in its products are...